LEF-1 is a prosurvival factor in chronic lymphocytic leukemia and is expressed in the preleukemic state of monoclonal B-cell lymphocytosis

Albert Gutierrez, Diane F. Jelinek(Mayo Clinic in Arizona)
Blood
July 2, 2010
10.1182/blood-2010-02-269878
Cited by 172

Related Papers

Ibrutinib–Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2019|735
Regulated Expression of BAFF-Binding Receptors during Human B Cell Differentiation
|The Journal of Immunology|2007|261
Platelet-derived growth factor (PDGF)–PDGF receptor interaction activates bone marrow–derived mesenchymal stromal cells derived from chronic lymphocytic leukemia: implications for an angiogenic switch
|Blood|2010|148
Selective Induction of DNA Repair Pathways in Human B Cells Activated by CD4+ T Cells
|PLoS ONE|2010|11